Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 3961 AL 3975

Metabolic Syndrome as a Risk Factor for Alzheimer's Disease: A Focus on Insulin Resistance

Ezkurdia A, Ramírez MJ, Solas M.

Int J Mol Sci. 2023 Feb 22;24(5):4354. doi: 10.3390/ijms24054354.

Metabolic perspective of astrocyte dysfunction in Alzheimer's disease and type 2 diabetes brains

Shen Z, Li ZY, Yu MT, Tan KL, Chen S.

Biomed Pharmacother. 2023 Feb;158:114206. doi: 10.1016/j.biopha.2022.114206. Epub 2023 Jan 5.

Kaempferol as a therapeutic agent in Alzheimer's disease: Evidence from preclinical studies

Dong X, Zhou S, Nao J.

Ageing Res Rev. 2023 Jun;87:101910. doi: 10.1016/j.arr.2023.101910. Epub 2023 Mar 15.

Abnormal white matter changes in Alzheimer's disease based on diffusion tensor imaging: A systematic review

Chen Y, Wang Y, Song Z, Fan Y, Gao T, Tang X.

Ageing Res Rev. 2023 Jun;87:101911. doi: 10.1016/j.arr.2023.101911. Epub 2023 Mar 15.

Acupressure Improves Cognition and Quality of Life Among Older Adults with Cognitive Disorders in Long-Term Care Settings: A Clustered Randomized Controlled Trial

Lin YK, Liao HY, Watson K, Yeh TP, Chen IH.

J Am Med Dir Assoc. 2023 Apr;24(4):548-554. doi: 10.1016/j.jamda.2023.02.011. Epub 2023 Mar 15.

Re-remembering the influence of randomized β-carotene on cognitive decline

Kopec RE, Chasman DI, Okereke OI, Sesso HD.

Alzheimers Dement. 2023 Aug;19(8):3718-3721. doi: 10.1002/alz.13018. Epub 2023 Mar 20.

Association of Central Auditory Processing Dysfunction With Preclinical Alzheimer's Disease

Byun MS, Chang M, Yi D, Ahn H, Han D, Jeon S, Jang H, Lee DY, Oh SH; KBASE Research Group.

Otolaryngol Head Neck Surg. 2023 Jul;169(1):112-119. doi: 10.1002/ohn.228. Epub 2023 Jan 29.

Beyond the amyloid hypothesis: how current research implicates autoimmunity in Alzheimer's disease pathogenesis

Chatanaka MK, Sohaei D, Diamandis EP, Prassas I.

Crit Rev Clin Lab Sci. 2023 Sep;60(6):398-426. doi: 10.1080/10408363.2023.2187342. Epub 2023 Mar 20.

Validity of Normative Volumetric Estimates from Open Access Software in Amnestic Mild Cognitive Impairment

Fountain-Zaragoza S, Horn O, Thorn KE, Kraal AZ, Benitez A.

J Prev Alzheimers Dis. 2023;10(2):236-243. doi: 10.14283/jpad.2023.19.

New insights toward molecular and nanotechnological approaches to antidiabetic agents for Alzheimer's disease

Pradhan SP, Sahu PK, Behera A.

Mol Cell Biochem. 2023 Dec;478(12):2739-2762. doi: 10.1007/s11010-023-04696-1. Epub 2023 Mar 22.

The Future of Cognitive Screening in Neurodegenerative Diseases

Umfleet LG, Bilder RM, Loring DW, Thames A, Hampstead BM, Bauer RM, Drane DL, Cavanagh L.

J Alzheimers Dis. 2023;93(1):47-59. doi: 10.3233/JAD-221077.

Insulin-like growth factor-2 is a promising candidate for the treatment and prevention of Alzheimer's disease

Fitzgerald GS, Chuchta TG, McNay EC.

CNS Neurosci Ther. 2023 Jun;29(6):1449-1469. doi: 10.1111/cns.14160. Epub 2023 Mar 27.

New Pathways Identify Novel Drug Targets for the Prevention and Treatment of Alzheimer's Disease

Penke B, Szűcs M, Bogár F.

Int J Mol Sci. 2023 Mar 11;24(6):5383. doi: 10.3390/ijms24065383.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias